image
AnaptysBio, Inc. ANAB
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 19.0
-5.8 %
$ 578 M
Market Cap
-3.23
P/E
INCOME STATEMENT
17.2 M REVENUE
66.78%
Growth Rates
1Year 66.78%
3Years -38.84%
5Years 27.97%
7Years 0.40%
10Years 12.08%
-164 M OPERATING INCOME
-42.77%
Growth Rates
1Year -42.77%
3Years -90.24%
5Years -19.77%
7Years -76.96%
10Years -41.02%
-164 M NET INCOME
-27.11%
Growth Rates
1Year -27.11%
3Years -101.73%
5Years -21.55%
7Years -68.41%
10Years -40.28%
EFFICIENCY
Earnings Waterfall AnaptysBio, Inc.
image
Revenue 17.2 M
Cost Of Revenue 2.38 M
Gross Profit 14.8 M
Operating Expenses 182 M
Operating Income -164 M
Other Expenses -792 K
Net Income -164 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 17.2 10.3 63.2 75.0 8.0 5.0 10.0 16.7 17.6 15.8 5.5
GROSS PROFIT
Cost Of Revenue 2.4 2.3 98.5 80.0 99.3 56.2 29.4 15.4 17.3 8.6 8.8
Gross Profit 14.8 8.0 (35.3) (5.0) (91.3) (51.2) (19.4) 1.3 0.3 7.2 (3.3)
OPERATING INCOME
Operating Expenses 181.6 125.4 120.0 98.9 115.4 71.7 38.8 19.7 20.9 11.0 10.8
Selling, General and Administrative Expenses 41.9 36.6 21.5 18.9 16.1 15.5 9.3 4.3 3.6 2.4 1.9
Research and Development Expenses 132.3 88.8 98.5 80.0 99.3 56.2 29.4 15.4 17.3 8.6 8.8
Operating Income (164.4) (115.2) (56.8) (23.9) (107.4) (66.7) (28.8) (3.0) (3.3) 4.9 (5.3)
PRE-TAX INCOME
Interest Income Expense 18.1 21.1 1.4 0 1.0 1.7 1.8 0.5 0.5 1.3 0.9
Total Other Income 0.8 (13.5) (1.0) 3.9 9.9 4.9 (1.3) (1.2) (1.9) (1.3) (0.3)
Pre-Tax Income (163.6) (128.7) (57.8) (19.9) (97.5) (61.8) (30.1) (4.3) (5.3) 3.5 (5.5)
NET INCOME
Tax Provision 4 K 24 K (0.6) 11 K (0.2) (0.2) 1.8 0.2 0.1 1.3 0.9
Net Income (163.6) (128.7) (57.2) (19.9) (97.3) (61.7) (30.1) (4.3) (5.4) 3.5 (5.5)
EPS 6.08 4.57 2.08 0.73 3.6 2.5 1.52 0.23 0.38 0.0164 0.0948